Yeast on drugs: Saccharomyces cerevisiae as a tool for anticancer drug research

Clinical and Translational Oncology

Volumn 9, Issue 4, 2007, Pages 221-228

  Menacho Marquez M ^a   Murguia J R ^a  

^a Ciudad Politécnica de la Innovación   (Spain)

Author keywords

Anticancer drug; Growth interference; Haploinsufficiency; Proteome chips; Saccharomyces cerevisiae; Synthetic lethality

Indexed keywords

ANTINEOPLASTIC AGENT; CALCINEURIN; CAMPTOTHECIN; CGP 604; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2 INHIBITOR; CYCLIN DEPENDENT KINASE 4; DNA FRAGMENT; FLAVOPIRIDOL; FLUOROURACIL; HYDROXYUREA; IMATINIB; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MESYLIC ACID METHYL ESTER; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; RAPAMYCIN; RETINOBLASTOMA PROTEIN; TACROLIMUS; TUNICAMYCIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE PROGRESSION; DNA MICROARRAY; DNA REPLICATION; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG RESEARCH; DRUG SCREENING; DRUG TARGETING; FUNCTIONAL GENOMICS; FUNGAL GENETICS; FUNGAL STRAIN; GENE DELETION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SEGREGATION; HUMAN; NONHUMAN; PHARMACOGENETICS; PROTEIN SYNTHESIS INHIBITION; SACCHAROMYCES CEREVISIAE; YEAST CELL; ANTIBIOTIC RESISTANCE; COMPARATIVE STUDY; DRUG EFFECT; FUNGAL GENE; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; METHODOLOGY; MUTATION; PROTEOMICS; REVIEW;

ANTINEOPLASTIC AGENTS; DNA, COMPLEMENTARY; DRUG DESIGN; DRUG RESISTANCE, FUNGAL; DRUG SCREENING ASSAYS, ANTITUMOR; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; GENETIC RESEARCH; GENOMICS; HUMANS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOMICS; SACCHAROMYCES CEREVISIAE;

EID: 34447103991     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0043-2     Document Type: Article

References (37)

1. Botstein D, Fink GR (1988) Yeast: An experimental organism for modern biology. Science 240:1439-1443
2. Cherry JM, Ball C, Weng S et al (1997) Genetic and physical maps of Saccharomyces cerevisiae. Nature 387:67-73
3. Goffeau A, Barrell BG, Bussey H et al (1996) Life with 6000 genes. Science 274:546-567
4. Foury F (1997) Human genetic diseases: A crosstalk between man and yeast. Gene 195:1-10
5. Marton MJ, DeRisi JL, Bennett HA et al (1998) Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med 4:1293-1301
6. Tong AH, Lesage G, Bader GD et al (2004) Global mapping of the yeast genetic interaction network. Science 303:414-419
7. Lum PY, Armour CD, Stepaniants SB et al (2004) Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 116:121-137
8. Birrell GW, Giaever G, Chu AM et al (2001) A genome-wide screen in Saccharomyces cerevisiae for genes affecting UV radiation sensitivity. Proc Natl Acad Sci USA 98:12608-12613
9. Guthrie G, Fink GR (1991) A guide to yeast genetics and molecular biology. Methods Enzymol 194:1-863
10. Que QQ, Winzeler EA (2002) Large-scale mutagenesis and functional genomics in yeast. Funct Integr Genomics 2:193-198
11. Gaber RF, Copple DM, Kennedy BK et al (1989) The yeast gene ERG6 is required for normal membrane function but is not essential for biosynthesis of the cell-cycle-sparking sterol. Mol Cell Biol 9:3447-3456
12. Balzi E, Goffeau A (1995) Yeast multidrug resistance: The PDR network. J Bioenerg Biomembr 27:71-76
13. Dunstan HM, Ludlow C, Goehle S et al (2002) Cell-based assays for identification of novel double-strand break inducing agents. J Natl Cancer Inst 94:88-94
14. Shalon D, Smith SJ, Brown PO (1996) A DNA microarray system for analyzing complex DNA simples using two-color fluorescent probe hybridization. Genome Res 6:639-645
15. Hughes TR, Marton MJ, Jones AR et al (2000) Functional discovery via a compendium of gene expression arrays. Cell 102:109-126
16. Rine J, Hansen W, Hardeman E, Davis RW (1983) Targeted selection of recombinant clones through gene dosage effects. Proc Natl Acad Sci U S A 80:6750-6754
17. Launhardt H, Hinnen A, Munder T (1998) Druginduced phenotypes provide a tool for the functional analysis of yeast genes. Yeast 14:935-942
18. Luesch H, Wu TY, Ren P et al (2005) Genomewide overexpression screen in yeast for smallmolecule target identification. Chem Biol 12: 55-63
19. Tugendreich S, Perkins E, Couto J et al (2001) A streamlined process to phenotypically profile heterologous cDNAs in parallel using yeast cellbased assays. Genome Biol 11:1899-2011
20. Perkins E, Sun D, Nguyen A et al (2001) Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. Cancer Res 61:4175-4183
21. Althaus FR, Richter C (1987) ADP-ribosylation of proteins. Enzymology and biological significance. Mol Biol Biochem Biophys 37:1-237
22. Entori L, Leonetti C, Scarsella M, D'Amati G (2003) Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma. Clin Cancer Res 9:5370-5379
23. Ortega S, Malumbres M, Barbacid M (2002) Cyclin D-dependent kinases, INK4A inhibitors and cancer. Biochim Biophys Acta 1602:73-87
24. Polyak K, Kato JY, Solomon MJ et al (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-a and contact inhibition to cell cycle arrest. Genes Dev 8:9-22
25. Quelle D Ashmun RA, Hannon GJ et al (1995) Cloning and characterization of murine p16INK4aand p15INK4b genes. Oncogene 11: 635-645
26. Moorthamer M, Panchal M, Greenhalf W, Chaudhuri B (1998) The p16(INK4A) protein and flavopiridol restore yeast cell growth inhibited by Cdk4. Biochem Biophys Res Commun 250:791-797
27. Xu Q, Reed JC (1998) Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol Cell 1:337-346
28. Giaever G, Flaherty P, Kumm J et al (1999) Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat Genet 21:278-283
29. Fang F, Hoskins J, Butler JS (2004) 5-Fluorouracil enhances exosome-dependent accumulation of polyadenylated rRNAs. Mol Cell Biol 24: 10766-10776
30. Giaever G, Flaherty P, Kumm J et al (2004) Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc Natl Acad Sci U S A 101:793-798
31. Parsons AB, Brost RL, Ding H et al (2004) Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat Biotechnol 22:62-69
32. Simon JA, Szankasi P, Nguyen DK et al (2000) Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae. Cancer Res 60:328-333
33. Chan TF, Carvalho J, Riles L, Zheng XF (2000) A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR). Proc Natl Acad Sci U S A 97:13227-13232
34. Chang, M, Bellaoui M, Boone C, Brown GW (2002) A genome-wide screen for methyl methanesulfonate-sensitive mutants reveals genes required for S phase progression in the presence of DNA damage. Proc Natl Acad Sci U S A 99:16934-16939
35. Martzen MR, McCraith SM, Spinelli SL et al (1999) A biochemical genomics approach for identifying genes by the activity of their products. Science 286:1153-1155
36. Zhu H, Bilgin M, Bangham R et al (2001) Global analysis of protein activities using protein chips. Science 293:2101-2105
37. Huang J, Zhu H, Haggarty SJ et al (2004) Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips. Proc Natl Acad Sci U S A 101:16594-16599